Clinical Trials Logo

Clinical Trial Summary

The Functional Assessment for Burns (FAB) score is an instrument developed by therapists at St Andrew's Burns Centre, Mid Essex Hospital Services NHS Trust, where it is currently used as standard protocol to measure the physical functional recovery and independence of adult burn inpatients. The aim of this research is to test the ability of the FAB score to collect accurate data when used by three different therapists observing the same patient carrying out specific functional tasks (i.e. inter-rater reliability).


Clinical Trial Description

Study purpose: Burn survivors face numerous physical challenges (e.g. reduced range of motion, upper/lower limb impairments, pain, swelling and itching) that affect activities of daily living (e.g. feeding, hygienic self-care, dressing, getting in/out of bed, walking and stair climbing). Assessment of physical function and independence, through valid and reliable instruments, is essential during inpatient rehabilitation of adult burn survivors in order to optimise their physical recovery and determine likely discharge outcomes. The FAB assessment is routinely carried out on patients at St Andrew's Burns Centre and the predictive validity of the FAB score has previously been tested in adult burn patients, however it has yet to be tested for inter-rater reliability. Therefore, the main purpose of this study is to investigate the ability of the FAB score to collect accurate data, free from measurement error, when used by multiple raters observing the same clinical episode. Study design: A quantitative reliability study will be carried out. All patients admitted to adult inpatients at St Andrew's Burn Centre will be screened and recruited according to inclusion/exclusion criteria by the Chief Investigator. There will be no change to patients' routine care as it is standard protocol for patients admitted to the burns ward to receive a FAB assessment within 48h of admission (FAB 1), and 48h of discharge (FAB 2), with interim assessments performed as necessary to monitor patients' progress and aid in maintaining motivation. In order to avoid any risk of potentially causing patients distress from too many assessing therapists, a maximum of three clinicians will be selected from a convenience sample of the burns inpatient therapy team (n=12). For each episode, the most clinically senior of the three raters will conduct the FAB assessment. Each rater will score the patient individually and will be blinded to the other observers' results. If a patient requires the assistance of more than one physiotherapist/occupational therapist to complete a task, the clinician is permitted to report, "I am assisting/supervising/not assisting", but not state how this would be represented as a FAB score. Data analysis: Scores from each assessment episode will be imported into MedCalc statistical package. Calculation of the Intraclass correlation coefficient (ICC) will assess the agreement (and therefore the inter-rater reliability) of the results provided by the three therapists, both as individual FAB score components, and as an overall functional outcome measure. The ICC values range between 0 and 1, with values ≥0.70 considered 'good' agreement. Therefore, the desired ICC for the study will be set at 0.70 and ICC values will be interpreted as follows: ≤0.50 poor agreement, 0.50-0.70 moderate agreement, 0.70-0.90 good agreement, ≥0.90 excellent agreement and 1.00 perfect agreement. The statistical analysis of the ICC is obtained by analysis of variance (ANOVA). As there will be three different raters for each scoring episode, a One-Way Random Effects Model will be used in a fully crossed study design. A One-Way model will allow flexibility of rater selection depending on therapists' availability, as consistent participation on a busy hospital ward will not be achievable. As this model will not be able to separate rater and total variance (i.e. rater and error variances combined), both error and rater variances must be small to achieve a desirable agreement level. Sample size: In order to determine a sample size for the ICC it is necessary to have the desired ICC value, the expected confidence level, and the confidence level associated with the confidence interval. As ICC values ≥0.70 are considered 'good' agreement, the ICC will be set at 0.70. The expected confidence interval width is determined by a pre-specified power of at least 0.8 with 95% confidence interval. The confidence level associated with the confidence interval is examined in graphical form, with expected 95% confidence interval width plotted against the desired ICC value. This reveals that for a sample size yielding a 95% confidence interval, and confidence levels not exceeding 0.56 (0.70 x 0.80), the study will require a minimum of 60 measurements (FAB scores). As three raters will be present for each assessment, this will therefore require a minimum of 20 patient scoring episodes. The study design, data analysis and sample size for this quantitative reliability study is based on a previous study investigating a different tool that uses a similar scoring method, the Functional Assessment for Burns in Critical Care (FAB-CC), at St Andrew's Burns Intensive Care Unit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06059183
Study type Observational
Source Mid and South Essex NHS Foundation Trust
Contact Sarah Smailes, PhD
Phone 01245516005
Email sarah.smailes@nhs.net
Status Not yet recruiting
Phase
Start date February 2024
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT05023135 - DeepView SnapShot Portable (DV-SSP): Device Training Study
Completed NCT05276869 - Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
Completed NCT04548635 - VR for Burn Dressing Changes at Home Phase 2/Phase 3
Not yet recruiting NCT06076031 - Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing N/A
Recruiting NCT05084248 - Vitamin D Deficiency in Adults Following a Major Burn Injury Phase 4
Completed NCT03113253 - TRANexamic Acid to Reduce Bleeding in BURN Surgery Phase 4
Recruiting NCT04090424 - Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT03159182 - Study of Silicone Material Inserts To Treat Burn Scars N/A
Recruiting NCT02904941 - Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns N/A
Completed NCT02681757 - Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT01437852 - StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns Phase 1
Completed NCT01214811 - Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Phase 3
Completed NCT01061502 - Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds Phase 1/Phase 2
Terminated NCT00822796 - Thermogard™ Efficacy Trial N/A
Terminated NCT00824681 - Effect of Music Therapy on Families of Burn Patients Phase 1
Terminated NCT00634166 - Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group Phase 4
Terminated NCT00464386 - Continuous Glucose Monitoring (POC) in the ICU N/A
Withdrawn NCT00216983 - Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding N/A